Search Results
483 results found for "Cost-efficient medications https://simplemedrx.top"
- Anavex Comments on Newly Released World Alzheimer Report 2013
The report forecasts that the cost and burden of caring for people with dementia will approximately triple According to the World Alzheimer Report 2013, the current worldwide cost of dementia including Alzheimer the individuals living with it, their loved ones and caregivers and our approach has always been to efficiently Maëlenn Guerchet on behalf of the Global Observatory for Ageing and Dementia Care, which is hosted at Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex CEO Writes Letter to Shareholders
We have also had the opportunity to update our corporate strategy in a way that will create the most selectively add new qualified members with public company experience and/or healthcare and specific medical derivatives in other indications in order to maximize its potential for addressing several critical medical projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Shareholder & Media
- Anavex Raises $2.6M in Private Placement and Conversion of Liabilities, Enters into $10M Financing
healthcare practice at Deutsche Bank, serving pharmaceutical, biotech, and diagnostic companies, and most Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Invited to File Funding Application for Phase 2a Clinical Trial of ANAVEX 2-73
Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Shareholder & Media
- Anavex Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs
at risk of developing the devastating disease and those in the early stages, when disease-modifying medications Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- ANAVEX 2-73 Restores Mitochondrial Functionality, Clocks Cell Death and Oxidative Stress
Now in its 11th year, the conference attracts leading international medical and scientific experts from Full details of the study are described on Anavex’s website at https://anavex.com//files/1303_ADPD_Valentine.pdf Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Appoints Tom Skarpelos as Director
Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- ANAVEX 2-73 Shown to Block Oxidative Stress, Preventing Onset of Alzheimer's Disease
Full details of the study are described on Anavex’s website at https://anavex.com//files/2012-10-17_ANAVEX Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex to Present at Neuroscience 2012 in New Orleans
Additional information is available at http://www.sfn.org/am2012/home.aspx. Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Recognizes Alzheimer's Action Day
Early detection can help individuals get the most effectiveness from currently available treatments and Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Presents Compelling Data at World's Largest Alzheimer's Conference
Montpellier and by Anavex Life Sciences Corp., details of the study are described on Anavex’s website https Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex to Present at Alzheimer's Association International Conference
Additional information about the conference is available at http://www.alz.org/aaic/. Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
